Items where authors include "Maughan, T."

Article

Schoenpflug, L.A., Chatzipli, A., Sirinukunwattana, K. et al. (23 more authors) (2025) Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis. The Journal of Pathology, 265 (2). pp. 184-197. ISSN 0022-3417

Lafarge, M.W. orcid.org/0000-0001-9235-783X, Domingo, E. orcid.org/0000-0003-4390-8767, Sirinukunwattana, K. et al. (17 more authors) (2024) Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy. npj Precision Oncology, 8. 89. ISSN 2397-768X

Lee, R.W., Danson, S. orcid.org/0000-0002-3593-2890, Elliot, M. et al. (8 more authors) (2022) Importance of clinical research for the UK's 10-year cancer plan. The Lancet Oncology, 23 (8). pp. 975-978. ISSN 1470-2045

Proceedings Paper

Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.

Domingo, E., Rathee, S., Blake, A. et al. (18 more authors) (2021) Abstract LB129: Stratification of radiotherapy and fluoropyrimidine-based chemotherapy from multi-omic profiling in rectal cancer biopsies. In: Cancer Research. AACR Annual Meeting 2021, 17-21 May 2021, Philadelphia, PA, USA. American Association for Cancer Research (AACR) , LB129.

Mukherjee, S., Hurt, C., Cox, C. et al. (17 more authors) (2020) Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial. In: Journal of Clinical Oncology. 2020 Gastrointestinal Cancers Symposium, 23-25 Jan 2020, San Francisco, CA, USA. American Society of Clinical Oncology , p. 373.